Skip to content

Clinical trials

Phase 2 Keloid trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Keloid Phase: Phase 2 Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20121
20131
20141
20181
20192
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Capstone Therapeutics2
Tirgan, Michael H., M.D.2
Beth Israel Deaconess Medical Center1
Icahn School of Medicine at Mount Sinai1
Novartis Pharmaceuticals1
RXi Pharmaceuticals, Corp.1
Sirnaomics1
State University of New York - Downstate Medical Center1
University of Pennsylvania1
miRagen Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Keloid12
Cicatrix5
Cicatrix, Hypertrophic2
Fibrosis1
Recurrence1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.